Trademarks = 10

Forward Citations = 36

Loading Chart...

9 inventors (with patents filed for the assignee):

David J Ellis (2 out of 14 patents)

David E Shields (2 out of 12 patents)

George P Miljanich (2 out of 31 patents)

4. Jinling Chen (1 out of 1 patent)

5. Matthew S Deaver (1 out of 1 patent)

6. Kalyan Nuguru (1 out of 1 patent)

7. Richard J Holl (1 out of 9 patents)

8. Lonnie Brent (1 out of 1 patent)

9. Janine North (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 12653826 - Methods of reducing the likelihood of carcinoid heart disease in patients with neuroendocrine tumors (2026-06-16),

2. 11406635 - Solid dosage forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate (2022-08-09),

3. 10857204 - Method for administering omega-conopeptide (2020-12-08),

4. 10307463 - Method for administering omega-conopeptide (2019-06-04),

Company Overview

Tersera Therapeutics LLC is a leading biopharmaceutical company focused on developing innovative therapies for rare and underserved diseases. With a strong commitment to research and development, Tersera Therapeutics is dedicated to improving the lives of patients through the discovery and delivery of novel treatments. Through collaboration with healthcare professionals and patient advocacy groups, Tersera Therapeutics is driving advancements in the field of rare disease medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#41 in Deerfield, IL

#2,840 in Illinois

#60,641 in US

Deerfield, IL, United States of America

Tersera Therapeutics LLC

Forward Citations = 36

9 inventors:

David J Ellis (2 out of 14 patents)

David E Shields (2 out of 12 patents)

George P Miljanich (2 out of 31 patents)

4. Jinling Chen (1 out of 1 patent)

5. Matthew S Deaver (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tersera Therapeutics LLC. Retrieved from https://idiyas.com/company/tersera-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]